Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pyrexia, SARS-CoV-2 test
Clinical narrative: Heart beating faster than usual; Swollen lymph nodes; Fatigue; High fever; Had Covid after the vaccine dose; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Heart beating faster than usual), LYMPHADENOPATHY (Swollen lymph nodes), FATIGUE (Fatigue), PYREXIA (High fever) and COVID-19 (Had Covid after the vaccine dose) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Heart beating faster than usual), LYMPHADENOPATHY (Swollen lymph nodes), FATIGUE (Fatigue), PYREXIA (High fever) and COVID-19 (Had Covid after the vaccine dose). At the time of the report, HEART RATE INCREASED (Heart beating faster than usual), LYMPHADENOPATHY (Swollen lymph nodes), FATIGUE (Fatigue), PYREXIA (High fever) and COVID-19 (Had Covid after the vaccine dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high High. On an unknown date, Heart rate: high High-heart beating faster than usual. On an unknown date, SARS-CoV-2 test: positive Positive and positive Positive-had Covid twice, once before dose and once after.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. It was reported that patient administered 1st dose of the Moderna Covid-19 Vaccine in the Spring of 2021 and also not sure if patient had received any more doses.Treatment information was not provided.  Company Comment: This regulatory authority case concerns a male patient with unknown age , with relevant medical history of Covid 19  , who experienced  non-serious , unexpected  , AESI event of Covid 19 , non-serious , unexpected events of heart rate increased , lymphadenopathy , and non-serious , expected event of fatigue and pyrexia . These events occurred on an unknown date after vaccination with the 1st dose of mRNA-1273 vaccine ( date of vaccination not reported).    It was reported that this patient had a SARS-COV-2 test positive test date done was unknown. The details surrounding the events like treatment information , medical consultation or  if any laboratories /diagnostic procedures done were not reported. Outcome of the events was reported as unknown. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.; Sender's Comments: This regulatory authority case concerns a male patient with unknown age , with relevant medical history of Covid 19  , who experienced  non-serious , unexpected  , AESI event of Covid 19 , non-serious , unexpected events of heart rate increased , lymphadenopathy , and non-serious , expected event of fatigue and pyrexia . These events occurred on an unknown date after vaccination with the 1st dose of mRNA-1273 vaccine ( date of vaccination not reported).    It was reported that this patient had a SARS-COV-2 test positive test date done was unknown. The details surrounding the events like treatment information , medical consultation or  if any laboratories /diagnostic procedures done were not reported. Outcome of the events was reported as unknown. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.